Table I.
A. Plasma Samples | |||
---|---|---|---|
| |||
Control (n = 7) | CRSwNP (n = 18) | p Value | |
Sex, no. (%) | 0.9428 | ||
Men | 3 (42.9) | 8 (44.4) | |
Women | 4 (57.1) | 10 (55.6) | |
Age, mean ± SD | 47.4 ± 23.6 | 40.2 ± 18.5 | 0.1629 |
Race, no. (%) | 0.4090 | ||
White | 3 (42.9) | 11 (61.1) | |
African American | 4 (57.1) | 7 (38.9) | |
Other | 0 (0) | 0 (0) | |
SNOT22 Score, mean ± SD | – | 49.3 ± 27.8 [14] | – |
| |||
B. Nasal Mucus Samples | |||
| |||
Control (n = 6) | CRSwNP (n = 11) | p Value | |
| |||
Sex, no. (%) | 0.7933 | ||
Men | 4 (66.7) | 8 (72.72) | |
Women | 2 (33.3) | 3 (27.3) | |
Age, mean ± SD | 35.5 ± 14.5 | 42.45 ± 21.92 | 0.4985 |
Race, no. (%) | 0.6905 | ||
White | 4 (66.7) | 7 (63.64) | |
African American | 2 (33.3) | 3 (27.27) | |
Other | 0 (0) | 1 (9.1) | |
SNOT22 Score, mean ± SD | – | 49.625 ± 20.27 [8] | – |
SNOT22 = sinonasal outcome test-22. SD = standard deviation. [n] = number of patients with available SNOT22 scores.